Ultraviolet-B Light Therapy and Allogeneic Stem Cell Transplantation in Treating Patients With Hematologic Malignancies
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
RATIONALE: Peripheral stem cell transplantation may be able to replace immune cells that were
destroyed by chemotherapy. Sometimes the transplanted cells from a donor are rejected by the
body's normal cells. Ultraviolet-B light therapy given before and after allogeneic stem cell
transplantation may help prevent this from happening.
PURPOSE: Clinical trial to study the effectiveness of combining ultraviolet-B light therapy
with allogeneic stem cell transplantation in treating patients who have hematologic
malignancies.